A precedential ruling holds cancer treatment dosing claims invalid under Section 112(a), erasing a nine-figure jury award.
Narrowing claims to one industry did not move them outside the abstract idea category.
A single carbon atom separated a provisional filing from the patent that relied on it for priority.
A unanimous ruling on what a patent holder must allege when a generic label carves out the patented use.
